General Information of the Compound
Compound ID
CP0035085
Compound Name
2-((2-phenethylphenoxy)methyl)pyridine
    Show/Hide
Synonyms
2-((2-phenethylphenoxy)methyl)pyridine
2-{[2-(2-phenylethyl)phenoxy]methyl}pyridine
CHEMBL216198
    Show/Hide
Structure
Formula
C20H19NO
Molecular Weight
289.378
Canonical SMILES
C(Cc1ccccc1OCc1ccccn1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C20H19NO/c1-2-8-17(9-3-1)13-14-18-10-4-5-12-20(18)22-16-19-11-6-7-15-21-19/h1-12,15H,13-14,16H2
    Show/Hide
InChIKey
XVQTWFFAIBVICX-UHFFFAOYSA-N
Physicochemical Property
logP
4.4458
Rotatable Bonds
6
Heavy Atom Count
22
Polar Areas
22.12
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11973809
SID: 17425647
ChEMBL ID
CHEMBL216198
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000034 Caco-2 Homo sapiens (Human)  1
1
EC50 = 100000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 2-{[2-(2-phenylethyl)phenoxy]methyl}pyridine )
Drug Name 2-{[2-(2-phenylethyl)phenoxy]methyl}pyridine
Target(s)
5-HT 1A receptor (HTR1A)
Inhibitor
Dopamine D2 receptor (D2R)
Inhibitor